A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors

NCT07636785 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Carcinoma (HCC)
Metastatic Uveal Melanoma
Renal Cell Carcinoma (RCC)
Nonsmall Cell Lung Cancer
Colorectal Cancer (CRC)

Interventions

DRUG: VMD-102

Sponsor

VM Discovery, Inc.